ScholarIQanswers from OpenAlex

EXPRESSION OF TOLL-LIKE RECEPTOR 4, CD14, AND NF-κB IN CHINESE PATIENTS WITH ULCERATIVE COLITIS

PaperCitations, authors & open-access status

EXPRESSION OF TOLL-LIKE RECEPTOR 4, CD14, AND NF-κB IN CHINESE PATIENTS WITH ULCERATIVE COLITIS is a paper indexed in ScholarIQ from OpenAlex.

How many citations does EXPRESSION OF TOLL-LIKE RECEPTOR 4, CD14, AND NF-κB IN CHINESE PATIENTS WITH ULCERATIVE COLITIS have?

ScholarIQcitation count

EXPRESSION OF TOLL-LIKE RECEPTOR 4, CD14, AND NF-κB IN CHINESE PATIENTS WITH ULCERATIVE COLITIS has 14 citations in the OpenAlex counts ScholarIQ stores.

When was EXPRESSION OF TOLL-LIKE RECEPTOR 4, CD14, AND NF-κB IN CHINESE PATIENTS WITH ULCERATIVE COLITIS published?

ScholarIQyear

EXPRESSION OF TOLL-LIKE RECEPTOR 4, CD14, AND NF-κB IN CHINESE PATIENTS WITH ULCERATIVE COLITIS has 2011 year in the ScholarIQ index.

What is the open-access status of EXPRESSION OF TOLL-LIKE RECEPTOR 4, CD14, AND NF-κB IN CHINESE PATIENTS WITH ULCERATIVE COLITIS?

ScholarIQoa status

EXPRESSION OF TOLL-LIKE RECEPTOR 4, CD14, AND NF-κB IN CHINESE PATIENTS WITH ULCERATIVE COLITIS has closed oa status in the ScholarIQ index.

What is the DOI of EXPRESSION OF TOLL-LIKE RECEPTOR 4, CD14, AND NF-κB IN CHINESE PATIENTS WITH ULCERATIVE COLITIS?

ScholarIQdoi

The DOI for EXPRESSION OF TOLL-LIKE RECEPTOR 4, CD14, AND NF-κB IN CHINESE PATIENTS WITH ULCERATIVE COLITIS is on the source record.

What is the PMID of EXPRESSION OF TOLL-LIKE RECEPTOR 4, CD14, AND NF-κB IN CHINESE PATIENTS WITH ULCERATIVE COLITIS?

ScholarIQpmid

The PMID for EXPRESSION OF TOLL-LIKE RECEPTOR 4, CD14, AND NF-κB IN CHINESE PATIENTS WITH ULCERATIVE COLITIS is on the source record.

What is the OpenAlex record for EXPRESSION OF TOLL-LIKE RECEPTOR 4, CD14, AND NF-κB IN CHINESE PATIENTS WITH ULCERATIVE COLITIS?

ScholarIQopenalex

The OpenAlex for EXPRESSION OF TOLL-LIKE RECEPTOR 4, CD14, AND NF-κB IN CHINESE PATIENTS WITH ULCERATIVE COLITIS is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial